Stock Screener App

Frei -

Installieren

15.06

0.73% 0.1156

Cullinan Therapeutics Inc (CGEM)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Cullinan Therapeutics Inc-Aktie (CGEM)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	-
Operating Expenses	0.60% 55.26	55.59	75.80	55.00	48.85
Operating Income/Loss	0.60% -55.26	-55.59	-75.80	-55.00	-48.85
Income/Loss From Continuing Operations Before Tax	0.20% -50.71	-50.61	-70.06	-48.50	-40.56
Income/Loss From Continuing Operations After Tax	0.20% -50.71	-50.61	-70.06	-48.50	-40.56
Net Income/Loss	0.20% -50.71	-50.61	-70.06	-48.50	-40.56
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

ROIV

$28.50

0.78%

RPRX

$50.76

2.57%

BNTX

$92.69

3.01%

INSM

$138.73

1.11%

RVMD

$147.88

0.02%

ONC

$305.60

2.86%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters